news 2 0 1 7

	Voluntis Receives FDA Clearance And CE Mark For Insulia® A First For Digital Applications Supporting Type 2 Diabetes Patients Treated With Basal Insulin
	ESYSTA, the first smart insulin pen that will see the light in 2017
	Letter in the 20th anniversary of clinidiabet.com